Sign Up to like & get
recommendations!
1
Published in 2019 at "Huisarts en wetenschap"
DOI: 10.1007/s12445-019-0213-9
Abstract: SamenvattingVoor COPD zijn veel inhalatiemedicijnen beschikbaar, maar bij matige en ernstige COPD is de combinatie LABA (langwerkende bèta-2-antagonisten)-LAMA (langwerkende muscarine-antagonisten) iets effectiever dan andere medicatie. Dat blijkt uit een analyse van trials waarin LABA, LAMA,…
read more here.
Keywords:
copd;
iets effectiever;
laba lama;
combinatie laba ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2017.08.008
Abstract: INTRODUCTION The 2017 update to the Global Initiative for Obstructive Lung Disease (GOLD) strategy document includes recommendations for treatment intensification or step-down in chronic obstructive pulmonary disease (COPD), although recognises that limited supporting information is…
read more here.
Keywords:
laba lama;
treatment;
study;
gold ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Respiratory medicine"
DOI: 10.1016/j.rmed.2021.106461
Abstract: BACKGROUND Lung function impairment in COPD is known to be related to reductions of left heart size, while short-term interventional trials with bronchodilators showed positive effects on cardiac parameters. We investigated whether COPD maintenance therapy…
read more here.
Keywords:
laba lama;
copd maintenance;
ics laba;
medication ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Current Medical Research and Opinion"
DOI: 10.1080/03007995.2022.2129229
Abstract: Abstract Chronic obstructive pulmonary disease (COPD) is a condition with a relevant clinical and economic burden. Only 10% to 40% of COPD patients reporting a regular use of respiratory medications, including those who suffered from…
read more here.
Keywords:
triple laba;
copd patients;
lama ics;
fixed triple ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Annals of the American Thoracic Society"
DOI: 10.1513/annalsats.201912-915oc
Abstract: RATIONALE There is uncertainty on the optimal first-line therapy for symptomatic COPD. Long-acting beta-2-receptor agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) have long been mainstays of treatment, though it is still not clear if dual…
read more here.
Keywords:
laba lama;
therapy;
lama;
lama monotherapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.753653
Abstract: Purpose: This real-world study evaluated the effectiveness of different inhalation therapies in patients with symptomatic chronic obstructive pulmonary disease (COPD) in China and also explored the relevant factors that influence the effectiveness of inhalation therapy.…
read more here.
Keywords:
inhalation therapy;
laba lama;
study;
patients treated ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Annals of Internal Medicine"
DOI: 10.7326/acpjc-2018-168-8-047
Abstract: Question In patients with chronic obstructive pulmonary disease (COPD), do long-acting 2-agonists (LABAs) or long-acting muscarinic antagonists (LAMAs) increase risk for cardiovascular (CV) events? Methods Design Nested casecontrol study using data from the Taiwan National…
read more here.
Keywords:
use;
long acting;
laba lama;
new use ... See more keywords